Risk Assessment

The subject of cancer risk assessment (S. Brudnoy, The Scientist, March 8, 1993, page 14) is of continuing interest to academic scientists, but even more important to regulatory agencies. This topic is not as controversial scientifically as some may make it. All human carcinogens are genotoxic; that is, they can react under suitable conditions with DNA and genes, a fact leading to analytical detection. An exception as a nongenotoxic human carcinogen is high levels of the hormone diethylstilbest

Written byJohn Weisburger
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Another element that needs consideration, as described by Brudnoy, is the question of cell duplication rates. In any case, however, there are sound methods to evaluate human cancer risks. It is intriguing that there is so much intellectual discussion on cancer risks when the removal or modification of the documented known cancer risks--namely, tobacco use and nutritional excesses (especially in regard to fat intake)--that overall account for about 90 percent of the current cancer burden in the Western world, receives so little attention and readily implemented control measures.

JOHN H. WEISBURGER
Director Emeritus
American Health Foundation
Valhalla, N.Y.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies